In this episode, we look at Novartis CEO Vas Narasimhan calling for a change in the US drug payment systems, arguing for new economic models to identify how much value a cure represents. Also, Italy's attempts at introducing a draft resolution to improve transparency in drug pricing at the World Health Assembly.
Presenter: Aparna Krishnan
Contributors: Joanna Fernandes, Christina Poschen
Producer: Aparna Krishnan
Create your
podcast in
minutes
It is Free